Mirte M. Streppel
Breda, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 18, 2026
Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOPANC-1 and -2 trials.
Journal: The British journal of surgery
Published: August 20, 2025
SUNRISE-CRC: a randomized phase II study of high-dose intermittent sunitinib versus trifluridine/tipiracil in metastatic colorectal carcinoma.
Journal: The oncologist
Published: April 02, 2025
Experiences of patients with metastatic colorectal cancer participating in a supervised exercise intervention during chemotherapy.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: June 10, 2024
Assessing the Usability of a Tumor Dashboard for Multidisciplinary Care Teams for First Time Users; First Exploration of a Comparative Participatory Cognitive Walkthrough to Show Mismatches in Cognitive Models.
Journal: Studies in health technology and informatics
Published: November 10, 2021
MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 13, 2013
Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells.
Journal: American journal of physiology. Cell physiology
Published: July 21, 2012
The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis.
Journal: Genes, chromosomes & cancer
Published: October 26, 2011
Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon.
Journal: Human pathology
Published: October 18, 2011
Last Updated: 09/26/2026